US Patent Issued to Neurocrine Biosciences, Sanofi on March 24 for "Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine" (American, French Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,634, issued on March 24, was assigned to Neurocrine Biosciences Inc. (San Diego) and Sanofi (Paris).

"Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine" was invented by Andrew Becker (San Diego), Scott Stirn (San Diego), Joel Radisson (Paris) and Christina Marie Costa (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the fields of chemistry and medicine, more particularly to processes for making 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl...